- Home
- NRXP vs IGA Comparison
NRXP vs IGA Comparison
Compare NRXP & IGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NRXP | IGA |
|---|---|---|
| Founded | 2015 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 151.1M | 162.0M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | NRXP | IGA |
|---|---|---|
| Price | $3.22 | $10.70 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $38.25 | N/A |
| AVG Volume (30 Days) | ★ 606.6K | 86.4K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 8.93% |
| EPS Growth | ★ 69.70 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,225,000.00 | N/A |
| Revenue This Year | $2,547.84 | N/A |
| Revenue Next Year | $1,591.73 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.65 | $9.21 |
| 52 Week High | $5.06 | $10.76 |
Technical Indicators
Market Signals| Indicator | NRXP | IGA |
|---|---|---|
| Relative Strength Index (RSI) | 40.81 | 65.46 |
| Support Level | $3.12 | $9.57 |
| Resistance Level | $3.62 | $10.75 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 21.35 | 93.90 |
Price Performance
Historical ComparisonAbout NRXP NRX Pharmaceuticals Inc.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
About IGA Voya Global Advantage and Premium Opportunity Fund of Beneficial Interest
Voya Global Advantage and Premium Opportunity Fund is a United States-based diversified, closed-end management investment company. The fund has two investment objectives. Its primary objective is to provide a high level of income, while the secondary objective is to seek capital appreciation. To achieve these objectives, the fund invests at least 80% of its managed assets in a portfolio of common stocks from various countries around the world, including the United States. Additionally, it uses an integrated derivatives strategies.